Home > Press > Newbridge Nanotechnology Index (NNIX) Announces Quarterly Rebalance
Abstract:
Newbridge Securities Corporation today announced the quarterly rebalancing and reconstitution of its Newbridge Nanotechnology Index (NYSE Arca: NNIX). This quarter saw no additions or deletions among the constituents, leaving the total number of companies included at 24. Constituents subject to the 10% index weight cap were Headwaters (NYSE: HW), FEI Co. (NASDAQ: FEIC), Amcol (NYSE: ACO), and Symyx Technologies (NASDAQ: SMMX). The NNIX ended the quarterly period at 900.07, up 1.9% from the last rebalance on November 17, 2006.
The Newbridge Nanotechnology Index (NNIX) has been constructed to track the stock market performance of companies that are currently active in nanotechnology. The Index is comprised of companies whose operations, based on our assessment of products, intellectual property, research initiatives and partnerships, include a significant focus on nanotechnology. Companies whose market capitalizations are very large relative to the scope of their nanotechnology operations are not included in order to preserve the "pure play" nature of the Index. Only companies with common stock or ADRs listed on a national market or exchange in the U.S. are eligible. The base date for the Index was June 30, 2004, at which time the base value for the Index was set at 1000. The NNIX is market cap weighted, rebalanced quarterly, and now includes 24 companies.
####
About Newbridge Securities Corporation
Newbridge is a full-service securities brokerage firm (Member: NASD & SIPC) and a subsidiary of Newbridge Financial, Inc., an integrated financial services company. The Newbridge Institutional Research department specializes in the analysis and coverage of companies that have a strategic focus on nanotechnology. More information is available at our websites http://www.newbridgereports.com and http://www.newbridgesecurities.com .
For important disclosures please visit: http://www.newbridgesecurities.com/research_rpt_discl.html. Additional information is available upon request.
For more information, please click here
Contacts:
David M. Keiter
Director of Research
954-334-3450 x115.
Copyright © Market Wire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||